大腸がん 細胞 は 化学療法 を 生き残る ため に ダイアパウズ の よう な DTP 状態 に 入る
Sumaiyah K Rehman1, Jennifer Haynes1, Evelyne Collignon2
1Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G 1L7, Canada.
Cell
|January 8, 2021
まとめ
癌細胞は化学療法で生き残るために 薬剤耐性持続状態 (DTP) に突入する. 特定のサブ集団ではなく すべての癌細胞が 胚性ダイアパウズに似た DTP になり得るのです
科学分野:
- 腫瘍学
- 発達生物学
- 遺伝学
背景:
- 薬剤耐性持続細胞 (DTP) は,がん細胞が化学療法や標的治療を回避し,腫瘍の再発を促します.
- DTPの形成の背後にあるメカニズムの理解は,がんにおける治療抵抗性の克服に不可欠です.
研究 の 目的:
- 患者による結腸直腸がんのモデルでDTPを特定し,特徴づけること.
- DTP形成のクローンダイナミクスと根本的なメカニズムを調査する.
主な方法:
- 結腸直腸がんモデルにおけるクローン複合性を追跡するために細胞バーコードを使用した.
- DTP形成のダイナミクスを分析するための応用数学モデリング.
- 胚性ダイアパウスの DTP 転写および機能プロフィールを比較した.
主要な成果:
- DTP状態に入り再発した腫瘍では,クローン複合性の減少は観察されなかった.
- 数学的モデルでは 全ての癌細胞が DTP になる能力が等しいことが示されています
- DTPは,胚性ダイアパウズと転写的および機能的類似性を示しています.
結論:
- 癌細胞は 薬剤耐性の状態に入るために ダイアパウスのような 発達的に保存されたメカニズムを使用します
- この発見は,この保存されたメカニズムをターゲットにすることで,DTPに対する新しい治療戦略を提供できると示唆しています.
- すべてのがん細胞は DTP になる可能性があり,耐性集団の根絶が難しいことを強調しています.
関連する概念動画
02:56Treatment Resistant Cancers
3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
02:40Cancer Stem Cells and Tumor Maintenance
5.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.3K
02:53Adaptive Mechanisms in Cancer Cells
6.1K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
02:07Tumor Progression
6.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.8K
01:15Drugs that Stabilize Microtubules
2.3K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.3K
02:37DNA Damage can Stall the Cell Cycle
9.7K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.7K